Ceragenix Pharmaceuticals, Inc.
1444 Wazee Street
Suite 210
Denver,
CO 80202
United States - Map
Phone: 720-946-6440
Fax: 303-534-1860
Web Site: http://www.ceragenix.com
| Ceragenix Pharmaceuticals, Inc. operates as a medical device company focusing on infectious diseases and dermatology in the United States. The company has two base technology platforms, which include Ceragenins for the treatment of infectious disease; and Barrier Repair for the treatment of dermatological disorders, including atopic dermatitis, neonatal skin disorders, and others. Its Ceragenin compounds are active against a range of gram positive and negative bacteria. The company uses its Ceragenin technology to formulate Cerashield antimicrobial coatings for medical devices. Its Barrier Repair technology is the platform for the development of two prescription topical creams, including EpiCeram, a prescription product for the treatment of dry skin conditions and to manage and relieve the burning and itching associated with various types of dermatoses, including eczema, irritant contact dermatitis, and radiation dermatitis; and NeoCeram, a pediatric barrier repair cream intended to create a skin barrier in premature infants and neonates. Ceragenix Pharmaceuticals was founded in 2002 is based in Denver, Colorado. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Steven S. Porter , 59
Chairman and Chief Exec. Officer |
N/A
| N/A | Mr. Jeffrey S. Sperber , 44
Chief Financial Officer, Principal Accounting Officer, Sec. |
N/A
| N/A | Mr. Carl Genberg , 57
Sr. VP of R&D |
N/A
| N/A | Mr. Russell L. Allen , 63
VP of Corp. Devel. |
N/A
| N/A | Dr. Peter Elias M.D., 68
Chairman of Scientific Advisory Board and Chief Scientific Officer |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.40% Nasdaq 
Profile
